Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
                                 
 

Journal of Pharmacogenomics & Pharmacoproteomics


Open Access
 
 
 
ISSN: 2153-0645
 
 
 
home » pharmacogenomics-pharmacoproteomics Rss Feed Rss Feed
 
 
 
 
 
In Association with
 

Upcoming Event

 

Upcoming Special Issues

Special issue entitled: "Omics of Metabolic Disorders" has been edited by
Editor Image
 
 

Victor P Andreev
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Miami Miller School of Medicine
USA
Tel. 305 243 3487
E-mail: VAndreev@med.miami.edu  

University Logo
 
Special issue entitled: "Applications of Pharmacogenomics" has been edited by
Editor Image
 
 

Jorge Duconge
Department of Pharmaceutical Sciences
University of Puerto Rico
USA
Tel. 787 758 2525
Fax 787 767 2796
E-mail: jorge.duconge@upr.edu

University Logo
 
Read More»
 

About the Journal

The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
 
Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.
 
The Journal of Pharmacogenomics & Pharmacoproteomics welcomes new innovations including but not limited to the field of drug development, pharmacogenomics, pharmacoproteomics, new discoveries in genomic targets, various drug responses due to genetic polymorphisms, chemogenomics, personalized medicines, drug dosage formulations, drug safety and its efficacy.

 

  Impact Factor: 1.05*
  Index Copernicus Value: 4.76

  NLM ID: 101575137

 
     

Pharmacogenomics and Pharmacoproteomics Journal is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Pharmacogenomics and Pharmacoproteomics. They provide a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Pharmacogenomics and Pharmacoproteomics research. The Pharmacogenomics and Pharmacoproteomics Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacogenomics and Pharmacoproteomics journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacogenomics and Pharmacoproteomics Open Access Journals are freely accessible to everyone immediately after publication.

 

OMICS International group is delighted to invite you to attend the 4th International Conference on Translational Medicine during october 26-28, 2015 Maryland, Baltimore, USA.
 

OMICS International organises 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies, 400+ symposiums and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
 

 

Submit manuscript at http://editorialmanager.com/omicsgroup/ or send as an email attachment to the Editorial Office at editor.jpp@omicsonline.org

 
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y

 

 

Recently published articles

Will Pharmacogenomics Take the Pain Out of Pain Medication?

Pramod B Mahajan

 
The Interactions between Food and Drug
 
Polymorphisms in Genes Encoding Metalloproteinase 9 and Lymphotoxin- Alpha can Influence Warfarin Treatment

Jéssica B Borges, Thiago DC Hirata, Alvaro Cerda, Cristina M Fajardo, Raony CC Cesar, João ID França, Jéssica C Santos, Hui-Tzu L Wang, Lara R Castro, Marcelo F Sampaio, Rosario DC Hirata, Mario H Hirata

 
The European Society of Pharmacogenomics and Personalised Therapy – ESPT

Siest G

 
Stimulation of Thermogenesis via Beta-Adrenergic and Thyroid Hormone Receptors Agonists in obesity Treatment – Possible Reasons for Therapy Resistance

Alina Kurylowicz

 
 
 
 
 
Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country
   USA    Spain
   Australia   Canada
   UAE   China
   Italy   France
   Germany   India
   UK   Malaysia
   Japan   Singapore
   Brazil   South Africa
  South Korea
 
Conferences By City
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
 
Conferences By Subject
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
 
 
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version